Frequent inactivation of p16INK4a in oral premalignant lesions - PubMed (original) (raw)
. 1997 Apr 17;14(15):1799-803.
doi: 10.1038/sj.onc.1201010.
Affiliations
- PMID: 9150385
- DOI: 10.1038/sj.onc.1201010
Frequent inactivation of p16INK4a in oral premalignant lesions
V Papadimitrakopoulou et al. Oncogene. 1997.
Abstract
Head and neck carcinogenesis is believed to be a multistep process, whereby genetic events accumulate in the carcinogen-exposed field at risk, resulting in distinct phenotypic premalignant changes that eventually evolve into invasive cancer. Frequent loss of heterozygosity (LOH) at the chromosome 9p21 region and inactivation of p16(INK4a) by different mechanisms have been described in head and neck squamous cell carcinoma (HNSCC). Recently, we reported that loss of 9p21 is also frequent in oral premalignant lesions. To investigate potential inactivation of p16(INK4a) in these premalignant lesions, we analysed 74 biopsies from 36 patients by immunohistochemistry (IHC) for expression of the p16 protein. Loss of p16 expression was found in 28 (38%) of the lesion biopsies from 17 patients (47%). LOH at the D9s171, a marker in the 9p21 region, was observed in 19 lesion biopsies from 12 cases and correlated with absence of p16 by IHC in 11 (92%) of the 12 comparable cases and 15 (79%) of 19 lesion biopsies. By direct sequencing of ten lesion biopsies from ten individuals with LOH at D9s171 for p16(INK4a) exon 2, one non-sense mutation at codon 88 (GGA-->TGA) was identified. Our data suggest that inactivation of p16(INK4a) may play an important role in early head and neck cancer development.
Similar articles
- Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, Weghorst CM. Kresty LA, et al. Cancer Res. 2002 Sep 15;62(18):5295-300. Cancer Res. 2002. PMID: 12234999 - Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
Grüttgen A, Reichenzeller M, Jünger M, Schlien S, Affolter A, Bosch FX. Grüttgen A, et al. J Pathol. 2001 Jul;194(3):311-7. doi: 10.1002/path.906. J Pathol. 2001. PMID: 11439363 - Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
Spanakis NE, Gorgoulis V, Mariatos G, Zacharatos P, Kotsinas A, Garinis G, Trigidou R, Karameris A, Tsimara-Papastamatiou H, Kouloukousa M, Manolis EN, Kittas C. Spanakis NE, et al. Anticancer Res. 1999 May-Jun;19(3A):1893-9. Anticancer Res. 1999. PMID: 10470133 - Novel management of oral cancer: a paradigm of predictive oncology.
Sudbø J. Sudbø J. Clin Med Res. 2004 Nov;2(4):233-42. doi: 10.3121/cmr.2.4.233. Clin Med Res. 2004. PMID: 15931363 Free PMC article. Retracted. Review. - Early genetic changes during upper aerodigestive tract tumorigenesis.
Hittelman WN, Voravud N, Shin DM, Lee JS, Ro JY, Hong WK. Hittelman WN, et al. J Cell Biochem Suppl. 1993;17F:233-6. doi: 10.1002/jcb.240531034. J Cell Biochem Suppl. 1993. PMID: 8412199 Review.
Cited by
- "Expression of p16 in oral leukoplakia and oral squamous cell carcinoma and correlation of its expression with individual atypical features".
Agarwal A, Kamboj M, Shreedhar B. Agarwal A, et al. J Oral Biol Craniofac Res. 2019 Apr-Jun;9(2):156-160. doi: 10.1016/j.jobcr.2019.03.002. Epub 2019 Mar 11. J Oral Biol Craniofac Res. 2019. PMID: 30963022 Free PMC article. No abstract available. - Oral cancer: risk factors and molecular pathogenesis.
Ram H, Sarkar J, Kumar H, Konwar R, Bhatt ML, Mohammad S. Ram H, et al. J Maxillofac Oral Surg. 2011 Jun;10(2):132-7. doi: 10.1007/s12663-011-0195-z. Epub 2011 Apr 22. J Maxillofac Oral Surg. 2011. PMID: 22654364 Free PMC article. - Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients.
Tripathi Bhar A, Banerjee S, Chunder N, Roy A, Sengupta A, Roy B, Roychowdhury S, Panda CK. Tripathi Bhar A, et al. J Cancer Res Clin Oncol. 2003 Nov;129(11):642-50. doi: 10.1007/s00432-003-0485-z. Epub 2003 Sep 3. J Cancer Res Clin Oncol. 2003. PMID: 14586645 - Oral cancer prediction by noninvasive genetic screening.
Poell JB, Wils LJ, Brink A, Dietrich R, Krieg C, Velleuer E, Evren I, Brouns ER, de Visscher JG, Bloemena E, Ylstra B, Brakenhoff RH. Poell JB, et al. Int J Cancer. 2023 Jan 15;152(2):227-238. doi: 10.1002/ijc.34277. Epub 2022 Sep 18. Int J Cancer. 2023. PMID: 36069231 Free PMC article. - Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer.
Sachdeva A, Dhawan D, Jain GK, Yerer MB, Collignon TE, Tewari D, Bishayee A. Sachdeva A, et al. Cancers (Basel). 2022 Dec 30;15(1):268. doi: 10.3390/cancers15010268. Cancers (Basel). 2022. PMID: 36612264 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical